LifeTech Scientific Corp
HKEX:1302

Watchlist Manager
LifeTech Scientific Corp Logo
LifeTech Scientific Corp
HKEX:1302
Watchlist
Price: 1.46 HKD 0.69%
Market Cap: 6.4B HKD
Have any thoughts about
LifeTech Scientific Corp?
Write Note

LifeTech Scientific Corp
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

LifeTech Scientific Corp
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
LifeTech Scientific Corp
HKEX:1302
Long-Term Debt
ÂĄ561.3m
CAGR 3-Years
96%
CAGR 5-Years
20%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Long-Term Debt
ÂĄ8.6m
CAGR 3-Years
-29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Long-Term Debt
ÂĄ24.7m
CAGR 3-Years
-75%
CAGR 5-Years
-24%
CAGR 10-Years
2%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Long-Term Debt
ÂĄ184.3m
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Long-Term Debt
ÂĄ1.2B
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Long-Term Debt
ÂĄ117.3m
CAGR 3-Years
162%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

LifeTech Scientific Corp
Glance View

Market Cap
6.8B HKD
Industry
Health Care

LifeTech Scientific Corp. is an investment holding company, which engages in the development, manufacture, research, development and market of minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders. The company is headquartered in Shenzhen, Guangdong and currently employs 943 full-time employees. The company went IPO on 2011-11-10. The firm operates through three business segments. The Congenital Heart Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to congenital and structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to peripheral vascular diseases. The Surgical Vascular Repair Business segment is engaged in the research and development, manufacture and trading of devices related to surgical vascular repair.

Intrinsic Value
2.06 HKD
Undervaluation 29%
Intrinsic Value
Price

See Also

What is LifeTech Scientific Corp's Long-Term Debt?
Long-Term Debt
561.3m CNY

Based on the financial report for Jun 30, 2024, LifeTech Scientific Corp's Long-Term Debt amounts to 561.3m CNY.

What is LifeTech Scientific Corp's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
20%

Over the last year, the Long-Term Debt growth was 284%. The average annual Long-Term Debt growth rates for LifeTech Scientific Corp have been 96% over the past three years , 20% over the past five years .

Back to Top